Risk factors for depresion and anxiety in the patient with aortic valve stenosis

Keywords: Anxiety, depression, stenosis valve aortic, risk of factors, prevalence

Abstract

Anxiety disorders and depression are common along with negative effects in different areas of the patient such as lower quality of life, lower adherence to treatment, negative perception of oneself along with underlying comorbidities and mortality, which is why these disorders are usually considered as symptoms and not as an independent factor that require greater detection, care and early treatment. Cardiovascular diseases are among the leading causes of mortality and morbidity in the world. Among them there is a subgroup of valvopathies which can occur in young patients (congenital alterations) and in elderly patients (called calcific or degenerative aortic valve stenosis) consisting of calcium crystal formation and lipid accumulation. These processes damage the valve generating aortic sclerosis characterized by thickening of the leaflets. Valvopathies are usually asymptomatic during the first years after their onset, and several modifiable and non-modifiable factors have been related to the progression of the disease. Psychological alterations can occur in these patients before, during and/or after discharge, generating mood disorders such as anxiety and depression, the frequency of which is unknown, which is why the general objective of the article is the importance of recognizing the symptomatology to favour prognosis through timely diagnosis to generate future interdisciplinary interventions and improve the quality of patients.

Downloads

Download data is not yet available.

References

Organización Mundial de la Salud OMS, Organización Panamericana de la Salud OPS. Enfermedades cardiovasculares [Internet]. 2017 May 17 [Cited 2023 Feb 20]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

Instituto Nacional de Estadística y Geografía INEGI. Características de las defunciones registradas en México durante 2020, Preliminar. [Internet] 2021 Jul 29 [Cited 2023 Feb 20]. Available from: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/DefuncionesRegistradas2020_Pre_07.pdf

Otto CM, Prendergast B. Aortic valve stenosis from patients at risk to severe valve obstruction. N. Engl. J. Med. 2014;371(8):744–56.

American Heart Association AHA. Aortic Valve Stenosis (AVS) and Congenital Defects [Internet]. [Cited 2023 Feb 20]. Available from: https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/aortic-valve-stenosis-avs

Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat. Rev. Dis. Primers. 2016;3(2):16006.

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics- 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–52.

Carità P, Coppola G, Novo G, Caccamo G, Guglielmo M, Balasus F, et al. Aortic stenosis: insights on pathogenesis and clinical implications. J. Geriati. Cardiol. 2016;13(6):489–98.

Peeters FECM, Meex SJR, Dweck MR, Aikawa E, Crijns HJGM, Schurgers LJ, et al. Calcific aortic valve stenosis: hard disease in the heart: A biomolecular approach towards diagnosis and treatment. Eur. Heart J. 2018;39(28):2618–24.

Oliveira Sá MPB, Cavalcanti LRP, Perazzo ÁM, Gomes RAF, Clavel MA, et al. Calcific Aortic Valve Stenosis and Atherosclerotic Calcification. Curr. Atheroscler. Rep. 2020;22(2):2.

Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):35–71.

Bonow RO, Greenland P. Population-wide trends in aortic stenosis incidence and outcomes. Circulation. 2015;131(11):969–71.

Grimard BH, Safford RE, Burns EL. Aortic Stenosis: Diagnosis and treatment. Am. Fam. Physician. 2016;93(5):371–8.

Harris AW, Pibarot P, Otto CM. Aortic Stenosis: Guidelines and evidence gaps. Cardiol. Clin. 2020;38(1):55–63.

Cevallos L, Peralta K, Ortiz W, Moyón G. Patogénesis y clínica de la estenosis aórtica. Am. J. Public Health. 2020;3(2):64-70.

DeLaney MC, Neth M, Thomas JJ. Chest pain triage: Current trends in the emergency departments in the United States. J. Nucl. Cardiol. 2017;24(6):2004–11.

Everett RJ, Clavel MA, Pibarot P, Dweck MR. Timing of intervention in aortic stenosis: a review of current and future strategies. Heart. 2018;104(24):2067–76.

von Alvensleben JC. Syncope and Palpitations: A review. Pediatr. Clin. North Am. 2020;67(5):801–10.

Obaya J. Nuevos enfoques en el tratamiento de la insuficiencia cardiaca: un cambio en la estrategia terapéutica. Aten. Primaria. 2022;54(5):102309.

Généreux P, Stone GW, O’Gara PT, Marquis-Gravel G, Redfors B, Giustino G, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J. Am. Coll. Cardiol. 2016;67(19):2263–88.

Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and management of depression in patients with cardiovascular disease. J. Am. Coll. Cardiol. 2019;73(14):1827–45.

Zhang Y, Chen Y, Ma L. Depression and cardiovascular disease in elderly: current understanding. J. Clin. Neurosci. 2018;47:1–5.

Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and anxiety in heart failure: A Review. Harv. Rev. Psychiatry. 2018;26(4):175–84.

Craske MG, Stein MB. Anxiety. Lancet. 2016;388(10063):3048–59.

Chen X, Xu L, Li Z. Autonomic neural circuit and intervention for comorbidity anxiety and cardiovascular disease. Front. Physiol. 2022;13:852891.

Kourkoveli P, Rammos S, Parissis J, Maillis A, Kremastinos D, Paraskevaidis I. Depressive symptoms in patients with congenital heart pisease: incidence and prognostic value of self-rating depression scales. Congenital Heart Dis. 2015;10(3):240–7.

Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int. J. Cardiol. 2009;137(2):158–64.

Eslami B, Sundin Ö, Macassa G, Khankeh HR, Soares JJF. Anxiety, depressive and somatic symptoms in adults with congenital heart disease. J. Psychosom Res. 2013;74(1):49–56.

Benderly M, Kalter-Leibovici O, Weitzman D, Blieden L, Buber J, Dadashev A, et al. Depression and anxiety are associated with high health care utilization and mortality among adults with congenital heart disease. Int. J. Cardiol. 2019;276:81–6.

Lebherz C, Frick M, Panse J, Wienstroer P, Brehmer K, Kerst G, et al. Anxiety and depression in adults with congenital heart disease. Front. Pediatr. 2022;10:1–10.

Dutta P, James JF, Kazik H, Lincoln J. Genetic and developmental contributors to aortic stenosis. Circ. Res. 2021;128(9):1330–43.

Wegermann ZK, Mack MJ, Arnold S v, Thompson CA, Ryan M, Gunnarsson C, et al. Anxiety and depression following aortic valve replacement. J. Am. Heart Assoc. 2022;11(9):024377.

Acuña-Valerio J, Rodas-Díaz MA, Macias-Garrido E, Posadas-Sánchez R, Juárez-Rojas JG, Medina-Urrutia AX, et al. Prevalencia y asociación de la calcificación valvular aórtica con factores de riesgo y aterosclerosis coronaria en población mexicana. Arch. Cardiol Méx. 2017;87(2):108–15.

Martínez-Quintana E, Girolimetti A, Jiménez-Rodríguez S, Fraguela-Medina C, Rodríguez-González F, Tugores A. Prevalence and predictors of psychological distress in congenital heart disease patients. J. Clin. Psychol. 2020;76(9):1705–18.

Khan MM, Lanctôt KL, Fremes SE, Wijeysundera HC, Radhakrishnan S, Gallagher D, et al. The value of screening for cognition, depression, and frailty in patients referred for TAVI. Clin. Interv. Aging. 2019;14:841–8.

Arora S, Misenheimer JA, Ramaraj R. Transcatheter aortic valve replacement: comprehensive review and present status. Tex. Heart Inst. J. 2017;44(1):29–38.

Olsson K, Näslund U, Nilsson J, Hörnsten Å. Hope and despair: patients’ experiences of being ineligible for transcatheter aortic valve implantation. Eur. J. Cardiovasc Nurs. 2019;18(7):593–600.

Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic valve replacement. N. Engl. J. Med. 2020;382(9):799–809.

Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic valve replacement. N. Engl. J. Med. 2012;366(18):1686–95.

Published
2023-07-05
How to Cite
Téllez-Girón , E. M. (2023). Risk factors for depresion and anxiety in the patient with aortic valve stenosis. Mexican Journal of Medical Research ICSA, 11(22), 41-47. https://doi.org/10.29057/mjmr.v11i22.10628